{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:00:58Z","timestamp":1781816458817,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1053\/j.jfas.2026.05.015","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:58:26Z","timestamp":1780070306000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative GLP-1 receptor agonist use is not associated with increased risk of pseudoarthrosis following midfoot fusion: a propensity-matched analysis"],"prefix":"10.1053","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9820-6025","authenticated-orcid":false,"given":"Alexander J","family":"Baur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4846-7605","authenticated-orcid":false,"given":"Jared","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0539-4052","authenticated-orcid":false,"given":"David","family":"Hallaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-1676","authenticated-orcid":false,"given":"Hikmat","family":"Chmait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1703-6969","authenticated-orcid":false,"given":"William H","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-324X","authenticated-orcid":false,"given":"Troy S","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jfas.2026.05.015_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108362","article-title":"Beyond 2020: modelling obesity and diabetes prevalence","volume":"167","author":"Ampofo","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/j.jfas.2026.05.015_bib0002","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/15347346251357070","article-title":"Charcot neuro-osteoarthropathy in diabetes: implications for diabetic foot ulcers, amputations, and survival","volume":"24","author":"Stergioti","year":"2025","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1053\/j.jfas.2026.05.015_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ijms25084346","article-title":"Assessment of thyroid carcinogenic risk and Safety profile of GLP1-RA semaglutide (Ozempic) therapy for Diabetes mellitus and obesity: a systematic literature review","volume":"25","author":"Feier","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.jfas.2026.05.015_bib0004","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.12968\/jowc.2020.29.Sup6.S19","article-title":"Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review","volume":"29","author":"Ramanujam","year":"2020","journal-title":"J Wound Care"},{"key":"10.1053\/j.jfas.2026.05.015_bib0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13018-025-06077-4","article-title":"Effectiveness of intramedullary nails in tibiotalocalcaneal arthrodesis for Charcot neuroarthropathy: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2025","journal-title":"J Orthop Surg Res"},{"key":"10.1053\/j.jfas.2026.05.015_bib0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","volume":"18","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1053\/j.jfas.2026.05.015_bib0007","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jare.2025.08.046","article-title":"GLP-1 and GIP: magic bullet for musculoskeletal diseases?","volume":"83","author":"Fang","year":"2026","journal-title":"J Adv Res"},{"key":"10.1053\/j.jfas.2026.05.015_bib0008","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin","volume":"6","author":"Meng","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1053\/j.jfas.2026.05.015_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2025.112746","article-title":"Perioperative glucagon-like peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: a large retrospective cohort study with two year follow up","volume":"56","author":"Pereira","year":"2025","journal-title":"Injury"},{"key":"10.1053\/j.jfas.2026.05.015_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.knee.2025.08.007","article-title":"GLP-1 agonists are protective against postoperative complications following total knee arthroplasty","volume":"57","author":"Ranson","year":"2025","journal-title":"Knee"},{"key":"10.1053\/j.jfas.2026.05.015_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jfas.2026.05.015_bib0012","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1177\/21925682251391693","article-title":"Association between preoperative GLP-1 receptor analog use and postoperative complications and mortality following lumbar fusion surgery","volume":"16","author":"Kesaria","year":"2026","journal-title":"Glob Spine J"},{"key":"10.1053\/j.jfas.2026.05.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1053\/j.jfas.2026.01.011","article-title":"The association of GLP-1 receptor agonists and outcomes following midfoot arthrodesis","volume":"65","author":"Bank","year":"2026","journal-title":"J Foot Ankle Surg"},{"key":"10.1053\/j.jfas.2026.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1177\/21925682251391693","article-title":"Association between preoperative GLP-1 receptor analog use and postoperative complications and mortality following lumbar fusion surgery","volume":"16","author":"Kesaria","year":"2026","journal-title":"Glob Spine J"},{"key":"10.1053\/j.jfas.2026.05.015_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.knee.2025.08.007","article-title":"GLP-1 agonists are protective against postoperative complications following total knee arthroplasty","volume":"57","author":"Ranson","year":"2025","journal-title":"Knee"},{"key":"10.1053\/j.jfas.2026.05.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2025.112746","article-title":"Perioperative glucagon-like peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: a large retrospective cohort study with two year follow up","volume":"56","author":"Pereira","year":"2025","journal-title":"Injury"},{"key":"10.1053\/j.jfas.2026.05.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jfas.2026.05.015_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1053\/j.jfas.2026.05.015_bib0022","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.jfas.2025.05.002","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes following ankle fracture open reduction and internal fixation","volume":"64","author":"Morningstar","year":"2025","journal-title":"J Foot Ankle Surg"},{"key":"10.1053\/j.jfas.2026.05.015_bib0023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/10711007251328370","article-title":"GLP-1 agonists\u2019 Effect on infection and union after Tibiotalar fusion, Subtalar fusion, triple arthrodesis","volume":"46","author":"Levidy","year":"2025","journal-title":"Foot Ankle Int"},{"issue":"5","key":"10.1053\/j.jfas.2026.05.015_bib0024","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1177\/21925682251396965","article-title":"Perioperative glucagon-like peptide-1 receptor agonist use is associated with lower pseudoarthrosis rates following long-segment spinal deformity correction: a propensity-matched analysis","volume":"16","author":"Stump","year":"2026","journal-title":"Glob Spine J"},{"key":"10.1053\/j.jfas.2026.05.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2025.124751","article-title":"The effect of GLP-1 receptor agonists on reoperation following anterior cervical discectomy and fusion","volume":"206","author":"Bank","year":"2026","journal-title":"World Neurosurg"},{"key":"10.1053\/j.jfas.2026.05.015_bib0026","doi-asserted-by":"crossref","DOI":"10.1053\/j.jfas.2026.02.007","article-title":"Association of GLP-1 receptor agonists with post-operative outcomes after Achilles tendon repair in obese patients","author":"Rai","year":"2026","journal-title":"J Foot Ankle Surg"},{"issue":"11","key":"10.1053\/j.jfas.2026.05.015_bib0027","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1177\/10711007251364187","article-title":"Preoperative GLP-1 receptor agonist use and postoperative outcomes following operative ankle fracture repair in patients with type 2 diabetes: a national database study","volume":"46","author":"White","year":"2025","journal-title":"Foot Ankle Int"},{"issue":"21","key":"10.1053\/j.jfas.2026.05.015_bib0028","first-page":"1529","article-title":"Are GLP-1 receptor agonists safe in spine surgery: a systematic review","volume":"50","author":"Younus","year":"2025","journal-title":"Spine"},{"key":"10.1053\/j.jfas.2026.05.015_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","volume":"18","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1053\/j.jfas.2026.05.015_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-015-9993-5","article-title":"Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis","volume":"97","author":"Driessen","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.jfas.2026.05.015_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/medicina58020224","article-title":"The impact of GLP1 agonists on bone metabolism: a systematic review","volume":"58","author":"Daniilopoulou","year":"2022","journal-title":"Medicina"},{"key":"10.1053\/j.jfas.2026.05.015_bib0032","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40618-019-01034-5","article-title":"Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis","volume":"42","author":"Yang","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.jfas.2026.05.015_bib0033","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","article-title":"Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice","volume":"81","author":"Pereira","year":"2015","journal-title":"Bone"},{"key":"10.1053\/j.jfas.2026.05.015_bib0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bcpt.12850","article-title":"Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on","volume":"122","author":"Hansen","year":"2018","journal-title":"Bone Cell Metab Basic Clin Pharma Tox"},{"key":"10.1053\/j.jfas.2026.05.015_bib0035","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-17-0278","article-title":"Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"236","author":"Mabilleau","year":"2018","journal-title":"J Endocrinol"},{"key":"10.1053\/j.jfas.2026.05.015_bib0036","article-title":"Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.jfas.2026.05.015_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3843","article-title":"Effects of glucagon-like peptide-1 receptor agonist on bone mineral density and bone turnover markers: a meta-analysis","volume":"40","author":"Kim","year":"2024","journal-title":"Diabetes Metab Res"},{"key":"10.1053\/j.jfas.2026.05.015_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.697442","article-title":"The impact of glucagon-like peptide 1 receptor agonists on bone metabolism and its possible mechanisms in osteoporosis treatment","volume":"12","author":"Xie","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1053\/j.jfas.2026.05.015_bib0039","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/cd22-0027","article-title":"Glucagon-like peptide 1 receptor agonists have the potential to revolutionize the attainment of target A1C levels in type 2 diabetes\u2014So why is their uptake so low?","volume":"41","author":"King","year":"2023","journal-title":"Clin Diabetes"},{"key":"10.1053\/j.jfas.2026.05.015_bib0040","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ekir.2022.07.167","article-title":"Hemoglobin A1c reduction with the GLP-1 receptor agonist semaglutide is independent of baseline eGFR: post hoc analysis of the SUSTAIN and PIONEER programs","volume":"7","author":"Cherney","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jfas.2026.05.015_bib0041","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/os.12047","article-title":"Effect of the blood HbA1c level on surgical treatment outcomes of diabetics with ankle fractures","volume":"5","author":"Liu","year":"2013","journal-title":"Orthop Surg"},{"key":"10.1053\/j.jfas.2026.05.015_bib0042","doi-asserted-by":"crossref","DOI":"10.1177\/2473011418S00253","article-title":"Relationship between hemoglobin A1c value and bone healing in diabetic ankle fractures treated operatively versus non-operatively","volume":"3","author":"Hughes","year":"2018","journal-title":"Foot Ankle Orthop"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725162600147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725162600147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:50:09Z","timestamp":1781815809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106725162600147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"alternative-id":["S106725162600147X"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2026.05.015","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative GLP-1 receptor agonist use is not associated with increased risk of pseudoarthrosis following midfoot fusion: a propensity-matched analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2026.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Foot and Ankle Surgeons. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}